Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
4.070
+0.100 (2.52%)
Jul 7, 2026, 1:10 PM EDT - Market open
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $1.22 billion as of July 7, 2026. Its market cap has increased by 107.34% in one year.
Market Cap
1.22B
Enterprise Value
1.13B
1-Year Change
107.34%
Ranking
Category
Stock Price
$4.07
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $1.22B, a decrease of -7.88%. That is a compound annual growth rate of -1.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 1.22B | 12.59% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 1.29B |
| Corvus Pharmaceuticals | 1.28B |
| Jade Biosciences | 1.26B |
| Avalyn Pharma | 1.23B |
| Alpha Tau Medical | 1.22B |
| Wave Life Sciences | 1.22B |
| EyePoint | 1.21B |
| ORIC Pharmaceuticals | 1.13B |